CYP20A1


CYP20A1: The Enzyme that Regulates Vitamin D Production

Description

Cytochrome P450 family 20 subfamily A member 1 (CYP20A1) is an enzyme responsible for catalyzing the hydroxylation of 25-hydroxyvitamin D3 (25(OH)D3) to 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), the active form of vitamin D. CYP20A1 is primarily expressed in the proximal convoluted tubule cells of the kidney and plays a crucial role in maintaining calcium and phosphate homeostasis, bone mineralization, and immune function.

Associated Diseases

Mutations or deficiencies in CYP20A1 can lead to several health conditions:

  • Vitamin D-Dependent Rickets Type 1: An inherited disorder caused by mutations in CYP20A1 that results in impaired conversion of 25(OH)D3 to 1,25(OH)2D3. This leads to severe bone deformities and growth retardation.
  • Pseudo-Vitamin D Deficiency Rickets: A rare condition characterized by normal levels of 25(OH)D3 but low levels of 1,25(OH)2D3 due to impaired CYP20A1 function. This results in similar symptoms as vitamin D-dependent rickets type 1.
  • Hypocalcemia and Hyperparathyroidism: Deficiencies in CYP20A1 can reduce 1,25(OH)2D3 levels, leading to impaired calcium absorption and subsequent hypocalcemia and hyperparathyroidism.

Did you Know ?

In the United States, the prevalence of vitamin D deficiency is estimated to be around 40%. Vitamin D deficiency can result from inadequate sunlight exposure, dietary deficiencies, or genetic variations that affect CYP20A1 function.



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.